Is QURE a good stock to buy? We came across a bullish thesis on uniQure N.V. on r/stocks by AntoniaFauci. In this article, we will summarize the bulls’ thesis on QURE. uniQure N.V.’s share was trading at $20.68 as of May 4th. QURE’s trailing and forward P/E were 2.68 and 5.04 respectively according to Yahoo Finance.
Pressmaster/Shutterstock.com
uniQure N.V. is a rare disease-focused biotech company developing gene therapies, highlighted by a breakthrough treatment for Huntington’s...
